Study of Connected Scales to Help Monitor Treatment in Adults with Myeloma or Non-Hodgkins Lymphoma

What this Trial Is About

Researchers are evaluating the use of connected scales for remote monitoring in patients with aggressive non-Hodgkins lymphoma or multiple myeloma who require chemotherapy treatment. This study aims to assess if daily weight measurements collected through a connected scale can help the medical team detect early changes in clinical parameters and improve patient care. The study is sponsored by Assistance Publique - Hf4pitaux de Paris and involves 30 patients. Participants will use a connected scale called Body Comp Pro from Withings once daily for about 7 weeks. Their weight and other clinical data will be monitored remotely via a platform accessible to the medical team. Alerts will be generated if abnormal changes occur, allowing timely medical interventions. The study focuses on how well patients accept and use the device and how it affects their care. During the study, patients will weigh themselves daily, ideally at the same time each day. The medical team will review the data and alerts remotely. Researchers will assess patient participation rates, ease of device use, anxiety related to the device, and the impact of alerts on care throughout the 7-week period. Participation requires signing informed consent, and the total involvement duration is approximately seven weeks.

Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients